Hoffmann-La Roche × Alzheimers
Hoffmann-La Roche alzheimers: 3 indexed trials, 0 recruiting studies across 1 countries in the current NeuroRisk corpus.
Request comparative brief →Indexed trials3
Recruiting0
Countries1
Indexed studies
NCT03114657A Study of Crenezumab Versus Placebo to Evaluate the Efficacy and Safety in Participants With Prodromal to Mild Alzheimer's Disease (AD)
United StatesPHASE3
United StatesPHASE3
NCT03491150An Open-Label Crenezumab Study in Participants With Alzheimer's Disease
United StatesPHASE3
United StatesPHASE3
NCT03443973Safety and Efficacy Study of Gantenerumab in Participants With Early Alzheimer's Disease (AD)
United StatesPHASE3
United StatesPHASE3
Enterprise comparison
Compare sponsor momentum, recruiting activity, geography and connected evidence with the broader NeuroRisk intelligence layer.
Request enterprise access →